Scynexis (SCYX) Total Current Liabilities (2013 - 2026)
Scynexis (SCYX) reported Total Current Liabilities of $15.9 million for Q1 2026, up 77.51% on a YoY basis from $9.0 million in Q1 2025, and up 177.29% quarter-over-quarter from $5.7 million in Q4 2025.
Scynexis (SCYX) Total Current Liabilities (2013 - 2026) Analysis & Trends
Scynexis has reported Total Current Liabilities for 14 years, with the latest figure at $15.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 77.51% year-over-year to $15.9 million; the trailing twelve-month figure through Mar 2026 stood at $15.9 million (up 77.51% YoY), and the FY2025 full-year result was $5.7 million, down 76.21% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $15.9 million, up from $5.7 million in the prior quarter.
- The five-year high for Total Current Liabilities was $45.6 million in Q1 2023, with the low at $5.7 million in Q4 2025.
- Historically, Total Current Liabilities has averaged $18.1 million across 5 years, with a median of $16.2 million in 2023.
- Annual changes were most pronounced in 2023 — Total Current Liabilities surged 252.63% — and 2025, when it tumbled 76.21%.
- Scynexis' Total Current Liabilities stood at $17.6 million in 2022, then declined by 7.46% to $16.3 million in 2023, then jumped by 47.82% to $24.1 million in 2024, then plunged by 76.21% to $5.7 million in 2025, then surged by 177.29% to $15.9 million in 2026.
- The last three Total Current Liabilities figures came in at $15.9 million (Q1 2026), $5.7 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.90 Mn |
| Dec 31, 2025 | 5.73 Mn |
| Sep 30, 2025 | 8.47 Mn |
| Jun 30, 2025 | 10.86 Mn |
| Mar 31, 2025 | 8.96 Mn |
| Dec 31, 2024 | 24.10 Mn |
| Sep 30, 2024 | 25.72 Mn |
| Jun 30, 2024 | 25.23 Mn |
| Mar 31, 2024 | 27.35 Mn |
| Dec 31, 2023 | 16.30 Mn |
| Sep 30, 2023 | 16.79 Mn |
| Jun 30, 2023 | 16.16 Mn |
| Mar 31, 2023 | 45.64 Mn |
| Dec 31, 2022 | 17.62 Mn |
| Sep 30, 2022 | 14.26 Mn |
| Jun 30, 2022 | 16.01 Mn |
| Mar 31, 2022 | 12.94 Mn |
| Dec 31, 2021 | 13.62 Mn |
| Sep 30, 2021 | 13.22 Mn |
| Jun 30, 2021 | 19.88 Mn |